These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions. Pindrus M; Shire SJ; Kelley RF; Demeule B; Wong R; Xu Y; Yadav S Mol Pharm; 2015 Nov; 12(11):3896-907. PubMed ID: 26407030 [TBL] [Abstract][Full Text] [Related]
4. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools. Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473 [TBL] [Abstract][Full Text] [Related]
5. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability. Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550 [TBL] [Abstract][Full Text] [Related]
6. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31. Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150 [TBL] [Abstract][Full Text] [Related]
7. Five computational developability guidelines for therapeutic antibody profiling. Raybould MIJ; Marks C; Krawczyk K; Taddese B; Nowak J; Lewis AP; Bujotzek A; Shi J; Deane CM Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4025-4030. PubMed ID: 30765520 [TBL] [Abstract][Full Text] [Related]
9. Modeling the impact of amino acid substitution in a monoclonal antibody on cation exchange chromatography. Saleh D; Hess R; Ahlers-Hesse M; Beckert N; Schönberger M; Rischawy F; Wang G; Bauer J; Blech M; Kluters S; Studts J; Hubbuch J Biotechnol Bioeng; 2021 Aug; 118(8):2923-2933. PubMed ID: 33871060 [TBL] [Abstract][Full Text] [Related]
10. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold. Perchiacca JM; Lee CC; Tessier PM Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633 [TBL] [Abstract][Full Text] [Related]
11. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance. Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043 [TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3. Paula S; Monson N; Ball WJ Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203 [TBL] [Abstract][Full Text] [Related]
13. Binding symmetry and surface flexibility mediate antibody self-association. Schrag JD; Picard MÈ; Gaudreault F; Gagnon LP; Baardsnes J; Manenda MS; Sheff J; Deprez C; Baptista C; Hogues H; Kelly JF; Purisima EO; Shi R; Sulea T MAbs; 2019 Oct; 11(7):1300-1318. PubMed ID: 31318308 [TBL] [Abstract][Full Text] [Related]
14. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618 [TBL] [Abstract][Full Text] [Related]
15. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions. Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ MAbs; 2015; 7(1):212-30. PubMed ID: 25559441 [TBL] [Abstract][Full Text] [Related]
16. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions. Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM Protein Eng Des Sel; 2012 Oct; 25(10):591-601. PubMed ID: 22843678 [TBL] [Abstract][Full Text] [Related]
17. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies. Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y MAbs; 2015; 7(3):553-61. PubMed ID: 25790175 [TBL] [Abstract][Full Text] [Related]
18. Structural classification of CDR-H3 revisited: a lesson in antibody modeling. Kuroda D; Shirai H; Kobori M; Nakamura H Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362 [TBL] [Abstract][Full Text] [Related]
19. Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter. Shimomura T; Sekiguchi M; Honda R; Yamazaki M; Yokoyama M; Uchiyama S Biol Pharm Bull; 2022; 45(9):1300-1305. PubMed ID: 36047198 [TBL] [Abstract][Full Text] [Related]
20. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody. Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB MAbs; 2015; 7(3):525-39. PubMed ID: 25875351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]